Gregory Monohan is a Hematology physician affiliated with University of Kentucky. OpenAlex indexes 66 publications with 397 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Rose Street
Cc446 Roach Bldg. Uk Hematology Clinic
Lexington, KY 405360093
Telephone
859-257-6006Provider last certified this registry record 28 Jul 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30.9%Thalidomide Analog21.5%Lenalidomide46%Revlimid29%Pomalyst25%Part D≥24 patientsKinase inhibitor6.1%Brukinsa38%Jakafi19%Sprycel17%Tasigna14%Calquence13%Part D<11 patients+ 3 more classes in this area
Dermatology
25.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor25.1%Acyclovir100%Part D≥71 patientsNervous system
17.8%Opioid Agonist8.1%Oxycodone Hcl55%Morphine Sulfate Er14%Oxycodone-Acetaminophen12%Morphine Sulfate10%Oxycontin10%Part D<11 patientsGabapentinoids4.9%Gabapentin79%Pregabalin21%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AI-driven risk stratification for disease progression after allo-SCT in AML.
Journal of Clinical Oncology
2025 - Bendamustine-Containing Regimens before CAR T-Cell Therapy Have Detrimental Effect on Progression-Free Survival
Biology of Blood and Marrow Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
David Moliterno, MD
University of Kentucky
Robert Dipaola
University of Kentucky
Darwin Conwell, MD
University of Kentucky
Phillip Tibbs
University of Kentucky
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”